In Vitro Proliferation of Porcine Pancreatic Islet Cells for β-Cell Therapy Applications

Simple item page
dc.contributor.authorNiu, Guoguangen
dc.contributor.authorMcQuilling, John P.en
dc.contributor.authorZhou, Yuen
dc.contributor.authorOpara, Emmanuel C.en
dc.contributor.authorOrlando, Giuseppeen
dc.contributor.authorSoker, Shayen
dc.contributor.departmentSchool of Biomedical Engineering and Sciencesen
dc.date.accessioned2017-09-18T09:34:39Zen
dc.date.available2017-09-18T09:34:39Zen
dc.date.issued2016-12-06en
dc.date.updated2017-09-18T09:34:39Zen
dc.description.abstractβ-Cell replacement through transplantation is the only curative treatment to establish a long-term stable euglycemia in diabetic patients. Owing to the shortage of donor tissue, attempts are being made to develop alternative sources of insulin-secreting cells. Stem cells differentiation and reprograming as well as isolating pancreatic progenitors from different sources are some examples; however, no approach has yet yielded a clinically relevant solution. Dissociated islet cells that are cultured in cell numbers by in vitro proliferation provide a promising platform for redifferentiation towards β-cells phenotype. In this study, we cultured islet-derived cells in vitro and examined the expression of β-cell genes during the proliferation. Islets were isolated from porcine pancreases and enzymatically digested to dissociate the component cells. The cells proliferated well in tissue culture plates and were subcultured for no more than 5 passages. Only 10% of insulin expression, as measured by PCR, was preserved in each passage. High glucose media enhanced insulin expression by about 4–18 fold, suggesting a glucose-dependent effect in the proliferated islet-derived cells. The islet-derived cells also expressed other pancreatic genes such as Pdx1, NeuroD, glucagon, and somatostatin. Taken together, these results indicate that pancreatic islet-derived cells, proliferated in vitro, retained the expression capacity for key pancreatic genes, thus suggesting that the cells may be redifferentiated into insulin-secreting β-like cells.en
dc.description.versionPublished versionen
dc.format.mimetypeapplication/pdfen
dc.identifier.citationGuoguang Niu, John P. McQuilling, Yu Zhou, Emmanuel C. Opara, Giuseppe Orlando, and Shay Soker, “In Vitro Proliferation of Porcine Pancreatic Islet Cells for β-Cell Therapy Applications,” Journal of Diabetes Research, vol. 2016, Article ID 5807876, 8 pages, 2016. doi:10.1155/2016/5807876en
dc.identifier.doihttps://doi.org/10.1155/2016/5807876en
dc.identifier.urihttp://hdl.handle.net/10919/78927en
dc.language.isoenen
dc.publisherHindawien
dc.rightsCreative Commons Attribution 4.0 Internationalen
dc.rights.holderCopyright © 2016 Guoguang Niu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.en
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/en
dc.titleIn Vitro Proliferation of Porcine Pancreatic Islet Cells for β-Cell Therapy Applicationsen
dc.title.serialJournal of Diabetes Researchen
dc.typeArticle - Refereeden
dc.type.dcmitypeTexten

Files

Original bundle
Now showing 1 - 2 of 2
Name:
JDR.2016.5807876.xml
Size:
6.17 KB
Format:
Extensible Markup Language
Download
Thumbnail Image
Name:
JDR.2016.5807876.pdf
Size:
1.95 MB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
Name:
license.txt
Size:
1.5 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Journal Articles, Hindawi Press
Scholarly Works, School of Biomedical Engineering and Sciences